Donor lymphocyte infusion administrations after allogeneic stem cell transplantations in pediatrics: A single center experience
dc.contributor.author | Aydoğdu, Selime | |
dc.contributor.author | Mergen, Azize | |
dc.contributor.author | Aksoy, Başak | |
dc.contributor.author | Akbay, Hazal S. | |
dc.contributor.author | Cipe, Funda | |
dc.contributor.author | Dikme, Gürcan | |
dc.contributor.author | Bozkurt, Ceyhun | |
dc.contributor.author | Fışgın, Tunç | |
dc.date.accessioned | 2021-05-15T11:34:29Z | |
dc.date.available | 2021-05-15T11:34:29Z | |
dc.date.issued | 2019 | |
dc.department | Tıp Fakültesi, Dahili Tıp Bilimleri | en_US |
dc.description | 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) -- MAR 24-27, 2019 -- Frankfurt, GERMANY | |
dc.description.abstract | Allogeneic stem cell transplantation (allo-SCT) is considered the cornerstone in the treatment of several malignant and not malignant hematological diseases. However, relapse of hematological disease after allo-SCT is considered the most challenging point in the field. The risk can be reduced through optimal patients, donor and disease selection before allo-SCT, but harnessing donor immune system is an appealing way to treat or avoid disease relapse. Donor lymphocyte infusion (DLI) is a simple and effective therapy after allo-SCT. In this paper, the efficacy of DLI will be analyzed in different hematological diseases, focusing also on their therapeutic or pre-emptive use. | en_US |
dc.description.sponsorship | European Soc Blood & Marrow Transplantat | en_US |
dc.identifier.endpage | 196 | en_US |
dc.identifier.issn | 0268-3369 | |
dc.identifier.issn | 1476-5365 | |
dc.identifier.startpage | 196 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12939/330 | |
dc.identifier.volume | 54 | en_US |
dc.identifier.wos | WOS:000487707800216 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.institutionauthor | Fışgın, Tunç | |
dc.institutionauthor | Akbay, Hazal S. | |
dc.language.iso | en | |
dc.publisher | Nature Publishing Group | en_US |
dc.relation.ispartof | Bone Marrow Transplantation | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Donors | en_US |
dc.subject | Allogeneic Stem Cell | en_US |
dc.subject | Pediatrics | en_US |
dc.title | Donor lymphocyte infusion administrations after allogeneic stem cell transplantations in pediatrics: A single center experience | |
dc.type | Conference Object |